139 related articles for article (PubMed ID: 9886331)
1. Elevated serum levels of soluble vascular cell adhesion molecule-1 (sVCAM-1) closely reflect tumour burden in chronic B-lymphocytic leukaemia.
Christiansen I; Sundström C; Tötterman TH
Br J Haematol; 1998 Dec; 103(4):1129-37. PubMed ID: 9886331
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of soluble intercellular adhesion molecule 1 are increased in chronic B-lymphocytic leukemia and correlate with clinical stage and prognostic markers.
Christiansen I; Gidlöf C; Wallgren AC; Simonsson B; Tötterman TH
Blood; 1994 Nov; 84(9):3010-6. PubMed ID: 7949173
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of soluble vascular cell adhesion molecule-1 (sVCAM-1) are elevated in advanced stages of non-Hodgkin's lymphomas.
Christiansen I; Sundström C; Kälkner KM; Bring J; Tötterman TH
Eur J Haematol; 1998 Nov; 61(5):311-8. PubMed ID: 9855246
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of soluble vascular cell adhesion molecule-1 (sVCAM-1) are elevated in advanced stages of non-Hodgkin's lymphomas.
Christiansen I; Sundström C; Kälkner KM; Bring J; Tötterman TH
Eur J Haematol; 1999 Mar; 62(3):202-9. PubMed ID: 10089899
[TBL] [Abstract][Full Text] [Related]
5. Soluble VCAM-1/soluble ICAM-1 ratio is a promising biomarker for diagnosing endometriosis.
Kuessel L; Wenzl R; Proestling K; Balendran S; Pateisky P; Yotova ; Yerlikaya G; Streubel B; Husslein H
Hum Reprod; 2017 Apr; 32(4):770-779. PubMed ID: 28333208
[TBL] [Abstract][Full Text] [Related]
6. Soluble vascular cell adhesion molecule-1 (sVCAM-1) is an independent prognostic marker in Hodgkin's disease.
Christiansen I; Sundström C; Enblad G; Tötterman TH
Br J Haematol; 1998 Aug; 102(3):701-9. PubMed ID: 9722296
[TBL] [Abstract][Full Text] [Related]
7. [Relation of the soluble cytoadhesion molecules VCAM-1 and ICAM-1 to selected clinical and laboratory indicators in multiple myeloma].
Scudla V; Budíková M; Bacovský J; Ordeltová M; Opíchalová D; Heincová V
Vnitr Lek; 1999 Oct; 45(10):583-90. PubMed ID: 10951865
[TBL] [Abstract][Full Text] [Related]
8. New indices of ischemic heart disease and aging: studies on the serum levels of soluble intercellular adhesion molecule-1 (ICAM-1) and soluble vascular cell adhesion molecule-1 (VCAM-1) in patients with hypercholesterolemia and ischemic heart disease.
Morisaki N; Saito I; Tamura K; Tashiro J; Masuda M; Kanzaki T; Watanabe S; Masuda Y; Saito Y
Atherosclerosis; 1997 May; 131(1):43-8. PubMed ID: 9180243
[TBL] [Abstract][Full Text] [Related]
9. Levels of soluble forms of ICAM and VCAM in patients with myelodysplastic syndromes and their prognostic significance.
Passam FH; Tsirakis G; Boula A; Fragou A; Consolas I; Alegakis A; Kyriakou DS; Alexandrakis MG
Clin Lab Haematol; 2004 Dec; 26(6):391-5. PubMed ID: 15595996
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of sIL2R, sCD23, sICAM-1, IL6 and sCD 14 serum levels in B-cell chronic lymphocytic leukemia.
Callea V; Morabito F; Luise F; Piromalli A; Filangeri M; Stelitano C; Iacopino P; Nobile F; Brugiatelli M
Haematologica; 1996; 81(4):310-5. PubMed ID: 8870374
[TBL] [Abstract][Full Text] [Related]
11. Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease.
Liakopoulos V; Eleftheriadis T; Kyropoulos T; Voliotis G; Potamianos S; Zengos N; Stefanidis I; Heintz B
Ren Fail; 2005; 27(3):315-21. PubMed ID: 15957549
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: association with malnutrition, inflammation, and cardiovascular disease.
Stenvinkel P; Lindholm B; Heimbürger M; Heimbürger O
Nephrol Dial Transplant; 2000 Oct; 15(10):1624-30. PubMed ID: 11007832
[TBL] [Abstract][Full Text] [Related]
13. [Relation of serum levels of the soluble cytoadhesion molecules sVCAM-1 and sICAM-1 to selected factors in the cytokine network in multiple myeloma].
Scudla V; Budíková M; Bacovský J; Opíchalová D; Farbiaková V
Cas Lek Cesk; 2000 Jul; 139(13):401-6. PubMed ID: 10971970
[TBL] [Abstract][Full Text] [Related]
14. [Assessment of serum levels of adhesion molecules (sICAM-1, sVCAM-1, sE-selectin) in stable and unstable angina and acute myocardial infarction].
Bossowska A; Kiersnowska-Rogowska B; Bossowski A; Galar B; Sowiński P
Przegl Lek; 2003; 60(7):445-50. PubMed ID: 14750416
[TBL] [Abstract][Full Text] [Related]
15. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
[TBL] [Abstract][Full Text] [Related]
16. Statins reduce oxidized low-density lipoprotein levels, but do not alter soluble intercellular cell-adhesion molecule-1 and vascular cell-adhesion molecule-1 levels in subjects with hypercholesterolaemia.
Rosenson RS; Wolff D; Tangney CC
Clin Sci (Lond); 2004 Feb; 106(2):215-7. PubMed ID: 12967321
[TBL] [Abstract][Full Text] [Related]
17. Soluble adhesion molecule profiling in preoperative infants with biliary atresia.
Davenport M; Gonde C; Narayanaswamy B; Mieli-Vergani G; Tredger JM
J Pediatr Surg; 2005 Sep; 40(9):1464-9. PubMed ID: 16150350
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the association of serum levels of hyaluronic acid, sICAM-1, sVCAM-1, and VEGF-A with mortality and prognosis in patients with Crimean-Congo hemorrhagic fever.
Ozturk B; Kuscu F; Tutuncu E; Sencan I; Gurbuz Y; Tuzun H
J Clin Virol; 2010 Feb; 47(2):115-9. PubMed ID: 20005156
[TBL] [Abstract][Full Text] [Related]
19. Relationship between lupus nephritis activity and the serum level of soluble VCAM-1.
Ikeda Y; Fujimoto T; Ameno M; Shiiki H; Dohi K
Lupus; 1998; 7(5):347-54. PubMed ID: 9696139
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer.
Kawano T; Yanoma S; Nakamura Y; Shiono O; Kokatu T; Kubota A; Furukawa M; Tsukuda M
Am J Otolaryngol; 2005; 26(5):308-13. PubMed ID: 16137528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]